Start-up Festival returns on 16 May in 📍 #London ➡️ ow.ly/2uTO50R8ncG

Looking forward to insights from👇
📌 Paul Ashley, Johnson & Johnson
📌 Amir Hasan, Ultromics
📌 Jelle Penders, SPARTA Biodiscovery
📌Hannah Sore, PharmEnable Therapeutics
📌Marcus Vass Penders Osborne Clarke

#BiotechStartups

We will be in Lisbon, Portugal for ESC #HeartFailure2024 from May 11th to 14th. Ultromics' mission is to improve heart failure patient outcomes using AI to help identify specific phenotypes, enabling early & timely treatment. Request to meet & learn more: hubs.la/Q02t-7qv0

New reimbursement codes enable adoption of AI echo solutions into clinical care. EchoGo® Heart Failure seamlessly integrates into the workflow, automating HFpEF detection. Learn how EchoGo® reclassifies 74% of indeterminate patients. hubs.la/Q02tkst_0 #HFpEF #CardioTwitter

📻 Great to have our HFpEF paper written with Dr.Patricia Pellikka featured on the ACCEL podcast. We found EchoGo® Heart Failure has 88% sensitivity & 82% specificity for HFpEF & detects patients with higher mortality risk. Listen here: acc.org/Latest-in-Card… #CardioTwitter #EchoFirst

❤️ Thank you to everyone who came to #ACC24 . It was great to connect with medical professionals dedicated to improving patients lives and discuss how Ultromics and AI can lead the way in demystifying the detection of HFpEF. #EchoFirst #CardioTwitter

Great to see our customers and friends at ACC. A great educational opportunity to meet with several customers and colleagues. Early precise detection of HFpEF for patients powered by AI continues to build momentum in a proven and scalable workflow. Ultromics

A recent study by @NadiraHamind demonstrated EchoGo®'s ability to diagnose HFpEF without invasive exercise hemodynamics and how our platform could detect HFpEF in interatrial shunt patients even in the absence of elevated hemodynamics. #ACC24 #CardioTwitter

👂Hear our CEO and Founder Ross Upton PhD explain how EchoGo® Heart Failure was validated across a multi-site trial. Our JACC Journals study showed EchoGo® Heart Failure reduced indeterminate diagnoses from 64% to 7% when compared to HFA-PEFF and H2FPEF scores. #EchoFirst #ACC24

🔊The wait is over, #ACC24 is here! Visit booth 1508 to learn how we use AI to revolutionize HFpEF detection. Discover how EchoGo Heart Failure significantly reduces indeterminate diagnosis. Request to meet ultromics.com/about/events #CardioTwitter

👂Hear our CEO and founder Ross Upton PhD speak at the Foundation for the National Institutes of Health AMP symposium where we partner with industry leaders from private & public sectors. Learn how HFpEF impacts patients & how EchoGo® Heart Failure aids detection.👉linkedin.com/feed/update/ur… #FNIH #EchoFirst

❤️It's that time of year again, get your name tags ready, conference season's here! We can't wait to see you and share our updates to EchoGo® Heart Failure and our new diagnostic modules (coming soon). Make an appointment to meet: hubs.la/Q02q8ZQ10 #CardioTwitter #EchoGo

Important ! Fact of the matter is invasive haemodynamics is not accessible to many, so this is definitely a much awaited tool #EchoFirst #HFpEF #HeartFailure

Two new studies now live, collaborations with Akhil Narang, MD & Nadira Hamid show EchoGo® Heart Failure identifies HFpEF patients accurately, without additional patient data hubs.la/Q02p4-gs0 and reduces the need for invasive tests! hubs.la/Q02p4YKh0
#CardioTwitter

Great to attend the American Society of Echocardiography Think Tank in New York, this weekend with fellow industry experts and leading scientists! Full of insightful panels and discussions around the current AI landscape in echocardiography and what the future holds. #ASEIRT #EchoFirst #CardioTwitter

Ultromics will be at #ACC24 in Atlanta from April 6th to 8th!
Stop by booth 1508 to discover how Ultromics is helping clinicians detect heart failure. Our AI platform, EchoGo® Heart Failure, detects #HFpEF from a single 4-chamber view. Request to meet: hubs.la/Q02nH1Md0

Our CEO & founder Ross Upton PhD introduces our AI diagnostic for #HFpEF detection at the FNIH AMP Symposium including findings on its performance in practice: youtube.com/watch?v=OlSsg6…

Ultromics is partnered with Foundation for the National Institutes of Health to find #PrecisionMedicine in #HFpEF ❤️ #AMPSymposium

Published in the Journal of Cardiac Failure Journal of Cardiac Failure 📖 'Unmasking HFpEF with Artificial Intelligence: A Disruptive Opportunity for Disease Detection'. Akhil Narang, MD presented study findings at #THT2024 today.

Official publication: onlinejcf.com/article/S1071-… #CardioTwitter

Dr Fudim Marat Marat Fudim, MD MHS presented his work with Dr Nadira Hamid at #THT2024 showing how our AI technology - EchoGo® Heart Failure - can support #HFpEF diagnosis without the need for invasive exercise hemodynamics. Learn more about EchoGo: hubs.ly/Q02n3lL20 #CardioTwitter